← Leaderboards
Donald Ym Leung
University Of Colorado Denver
$75,548,590
Attributed
$88,954,467
Total exposure
46
Grants
36
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$119,594,399 · 47
By mechanism
U19$51,456,856 · 4
UM1$35,545,811 · 2
U01$16,790,916 · 3
R01$8,431,107 · 2
P01$2,239,622 · 3
N01$2,000,000 · 2
Top collaborators
- Elena Goleva17 shared
- Gideon Lack12 shared
- Kari C. Nadeau12 shared
- Jeffrey A Kern5 shared
- Mario Lacouture5 shared
- Helen A Brough3 shared
- Susan Chan3 shared
Others in their field
Top investigators on “Atopic Dermatitis”
- David Leung · National Jewish Health$31,859,607
- Samuel Arbes · Univ Of North Carolina Chapel Hill$30,600,034
- Richard L Gallo · University Of California, San Diego$20,144,691
- Gurjit K Khurana Hershey · Children'S Hospital Med Ctr (Cincinnati)$16,546,601
- Steven F Ziegler · Seattle Children'S Hospital$14,953,425
- Raif Salim Geha · Children'S Hospital Boston$14,737,979
Research focus
Atopic DermatitisSkinResponseStaphylococcus AureusClinical ResearchInflammationCellsSkin BarrierAsthmaCytokineImmune ResponseGenesFunctional DisorderSamplingChildPathway InteractionsBiopsyInterleukin-13Food HypersensitivitySkin DisorderUnited States National Institutes Of HealthFundingResearch PersonnelGrant
Grant awards (145)
ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER$4,349,476
UM1 · FY2025 · AI · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER$3,500,000
UM1 · FY2025 · AI · contact PI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$1,811,466
U01 · FY2025 · AI
ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER$329,638
U01 · FY2025 · AI · contact PI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$205,350
U01 · FY2025 · AI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$150,239
U01 · FY2025 · AI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$126,846
U01 · FY2025 · AI
ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER$4,354,533
UM1 · FY2024 · AI · contact PI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$1,811,164
U01 · FY2024 · AI
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy$608,731
U01 · FY2024 · AR · contact PI
Admin Supp UK - SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$332,196
U01 · FY2024 · AI
ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER$329,638
U01 · FY2024 · AI · contact PI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$150,239
U01 · FY2024 · AI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$33,115
U01 · FY2024 · AI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$1,883,383
U01 · FY2023 · AI
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy$613,843
U01 · FY2023 · AR · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER$365,381
UM1 · FY2023 · AI · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER$329,638
U01 · FY2023 · AI · contact PI
National Jewish Health CoFAR Clinical Research Unit$234,998
UM1 · FY2023 · AI · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER$3,724,397
UM1 · FY2022 · AI · contact PI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$1,738,431
U01 · FY2022 · AI
ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER$1,599,999
UM1 · FY2022 · AI · contact PI
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy$610,938
U01 · FY2022 · AR · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER$329,638
U01 · FY2022 · AI · contact PI
National Jewish Health CoFAR Clinical Research Unit$234,998
UM1 · FY2022 · AI · contact PI
Experimental and Computational Analysis of the Human Epidemiology and Response to SARS-CoV-2 (HEROS) Cohort$5,634,911
UM1 · FY2021 · AI · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER$3,366,965
UM1 · FY2021 · AI · contact PI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$1,744,282
U01 · FY2021 · AI
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy$604,257
U01 · FY2021 · AR · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER$329,638
U01 · FY2021 · AI · contact PI
Experimental and Computational Analysis of the Human Epidemiology and Response to SARS-CoV-2 (HEROS) Cohort$328,499
UM1 · FY2021 · AI · contact PI
National Jewish Health CoFAR Clinical Research Unit$234,998
UM1 · FY2021 · AI · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER$4,394,468
UM1 · FY2020 · AI · contact PI
Experimental and Computational Analysis of the Human Epidemiology and Response to SARS-CoV-2 (HEROS) Cohort$2,282,196
UM1 · FY2020 · AI · contact PI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier$1,750,000
U01 · FY2020 · AI
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy$638,608
U01 · FY2020 · AR · contact PI
ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER$329,638
U01 · FY2020 · AI · contact PI
The Role of Bacterial Toxins in Human Skin Disease$321,302
R01 · FY2020 · AR · contact PI
National Jewish Health CoFAR Clinical Research Unit$234,998
UM1 · FY2020 · AI · contact PI
Overall Atopic Dermatitis Research Network$5,849,626
U19 · FY2019 · AI · contact PI
Administrative Core Atopic Dermatitis Research Network$2,044,056
U19 · FY2019 · AI · contact PI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum$1,441,997
U19 · FY2019 · AI · contact PI
Determinants of S. aureus Colonization in Atopic Dermatitis$764,791
U19 · FY2019 · AI · contact PI
The Role of Bacterial Toxins in Human Skin Disease$331,088
R01 · FY2019 · AR · contact PI
National Jewish Health CoFAR Clinical Research Unit$234,998
UM1 · FY2019 · AI · contact PI
Overall Atopic Dermatitis Research Network$5,920,878
U19 · FY2018 · AI · contact PI
Administrative Core Atopic Dermatitis Research Network$2,072,637
U19 · FY2018 · AI · contact PI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum$1,259,758
U19 · FY2018 · AI · contact PI
Determinants of S. aureus Colonization in Atopic Dermatitis$835,208
U19 · FY2018 · AI · contact PI
The Role of Bacterial Toxins in Human Skin Disease$351,859
R01 · FY2018 · AR · contact PI
National Jewish Health CoFAR Clinical Research Unit$234,998
UM1 · FY2018 · AI · contact PI
Overall Atopic Dermatitis Research Network$6,000,000
U19 · FY2017 · AI · contact PI
Administrative Core Atopic Dermatitis Research Network$2,041,925
U19 · FY2017 · AI · contact PI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum$1,473,611
U19 · FY2017 · AI · contact PI
Determinants of S. aureus Colonization in Atopic Dermatitis$747,753
U19 · FY2017 · AI · contact PI
The Role of Bacterial Toxins in Human Skin Disease$365,496
R01 · FY2017 · AR · contact PI
National Jewish Health CoFAR Clinical Research Unit$234,998
UM1 · FY2017 · AI · contact PI
Overall Atopic Dermatitis Research Network$6,869,429
U19 · FY2016 · AI · contact PI
Administrative Core Atopic Dermatitis Research Network$3,632,273
U19 · FY2016 · AI · contact PI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum$1,446,644
U19 · FY2016 · AI · contact PI
The Role of Bacterial Toxins in Human Skin Disease$355,297
R01 · FY2016 · AR · contact PI
Determinants of S. aureus Colonization in Atopic Dermatitis$5,913
U19 · FY2016 · AI · contact PI
Overall Atopic Dermatitis Research Network$5,999,999
U19 · FY2015 · AI · contact PI
Administrative Core Atopic Dermatitis Research Network$1,954,688
U19 · FY2015 · AI · contact PI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum$1,095,670
U19 · FY2015 · AI · contact PI
The Role of Bacterial Toxins in Human Skin Disease.$301,961
R01 · FY2014 · AR · contact PI
The Role of Bacterial Toxins in Human Skin Disease.$292,718
R01 · FY2013 · AR · contact PI
Mechanisms of Steroid Resistant Asthma$430,820
R56 · FY2012 · AI · contact PI
The Role of Bacterial Toxins in Human Skin Disease.$308,124
R01 · FY2012 · AR · contact PI
Mechanisms of steroid resistant asthma$505,980
R01 · FY2011 · AI · contact PI
The role of bacterial toxins in human skin disease.$308,124
R01 · FY2011 · AR · contact PI
Mechanisms of Steroid-$236,123
P01 · FY2011 · HL · contact PI
Mechanisms of steroid resistant asthma$511,072
R01 · FY2010 · AI · contact PI
Mechanisms of Steroid-$324,439
P01 · FY2010 · HL · contact PI
The role of bacterial toxins in human skin disease.$320,963
R01 · FY2010 · AR · contact PI
Atopic Dermatitis and Vaccinia Immunization Network Clinical Consortium$2,000,000
N01 · FY2009 · AI · contact PI
Mechanisms of steroid resistant asthma$501,197
R01 · FY2009 · AI · contact PI
The role of bacterial toxins in human skin disease$287,017
R01 · FY2009 · AR · contact PI
Mechanisms of steroid resistant asthma$486,600
R01 · FY2008 · AI · contact PI
The role of bacterial toxins in human skin disease$287,017
R01 · FY2008 · AR · contact PI
BLOOD DRAWING FOR OPTIMIZATION OF PROCEDURES$3,915
M01 · FY2008 · RR · contact PI
ADVN BIOMARKER STUDY$3,045
M01 · FY2008 · RR · contact PI
ROLE OF ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AGAINST VACCINIA$2,966
M01 · FY2008 · RR · contact PI
IMMUNOLOGIC MARKERS OF SEVERE REFRACTORY ATOPIC DERMATITIS$2,571
M01 · FY2008 · RR · contact PI
GENETICS OF ATOPIC DERMATITIS: ECZEMA HERPETICUM STUDY$2,096
M01 · FY2008 · RR · contact PI
ROLE OF BACTERIAL TOXINS IN ATOPIC DERMATITIS$1,740
M01 · FY2008 · RR · contact PI
MECHANISMS OF CORTICOSTEROID RESISTANT ASTHMA$593
M01 · FY2008 · RR · contact PI
Mechanisms of steroid resistant asthma$481,577
R01 · FY2007 · AI · contact PI
The role of bacterial toxins in human skin disease$292,874
R01 · FY2007 · AR · contact PI
ROLE OF BACTERIAL TOXINS IN ATOPIC DERMATITIS$39,721
M01 · FY2007 · RR · contact PI
BLOOD DRAWING FOR OPTIMIZATION OF PROCEDURES$33,999
M01 · FY2007 · RR · contact PI
ADVN BIOMARKER STUDY$30,632
M01 · FY2007 · RR · contact PI
ROLE OF ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AGAINST VACCINIA$29,622
M01 · FY2007 · RR · contact PI
MECHANISM OF STEROID RESISTANT ASTHMA$21,881
M01 · FY2007 · RR · contact PI
GENETICS OF ATOPIC DERMATITIS: ECZEMA HERPETICUM STUDY$17,841
M01 · FY2007 · RR · contact PI
MECHANISMS OF CORTICOSTEROID RESISTANT ASTHMA$11,445
M01 · FY2007 · RR · contact PI
IMMUNE RESPONSE TO VARICELLA VACCINATION IN PATIENTS WITH AD$2,356
M01 · FY2007 · RR · contact PI
IMMUNOLOGIC MARKERS OF SEVERE REFRACTORY ATOPIC DERMATITIS$1,010
M01 · FY2007 · RR · contact PI
The Role of bacterial toxins in human skin disease.$301,621
R01 · FY2006 · AR · contact PI
Glucocorticoid Resistance in Acute Lung Injury$266,128
P01 · FY2006 · HL · contact PI
MECHANISMS OF CORTICOSTEROID RESISTANT ASTHMA$49,510
M01 · FY2006 · RR · contact PI
ROLE OF ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AGAINST VACCINIA$30,634
M01 · FY2006 · RR · contact PI
ROLE OF BACTERIAL TOXINS IN ATOPIC DERMATITIS$17,329
M01 · FY2006 · RR · contact PI
ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$16,710
M01 · FY2006 · RR · contact PI
MECHANISMS OF ECZEMA VACCINATUM$2,476
M01 · FY2006 · RR · contact PI
SAFETY AND IMMUNOGENICITY OF THE VARICELLA ZOSTER VACCINE$2,166
M01 · FY2006 · RR · contact PI
ATOPIC DERMITITIS VACCINIA NETWORK /ADVN/-266040029$0
N01 · FY2006 · AI · contact PI
The role of bacterial toxins in human skin disease$308,880
R01 · FY2005 · AR
MECHANISMS OF STEROID RESISTANT ASTHMA$264,498
P01 · FY2005 · HL
Glucocorticoid Resistance in Acute Lung Injury$252,187
P01 · FY2005 · HL
IMMUNOMODULATION OF VACCINIA-INDUCED ANTIMICROBIAL PEPT*$75,800
R21 · FY2005 · AR
MECHANISMS OF CORTICOSTEROID RESISTANT ASTHMA$53,470
M01 · FY2005 · RR
ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$43,177
M01 · FY2005 · RR
MECHANISMS OF ECZEMA VACCINATUM$572
M01 · FY2005 · RR
SAFETY AND IMMUNOGENICITY OF THE VARICELLA ZOSTER VACCINE$286
M01 · FY2005 · RR
PATHOGENESIS AND ETIOLOGY OF KAWASAKI SYNDROME.$256,368
R37 · FY2004 · HL
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$216,858
R01 · FY2004 · AR
IMMUNOMODULATION OF VACCINIA-INDUCED ANTIMICROBIAL PEPT*$75,800
R21 · FY2004 · AR
Mechanisms of Corticosteroid Resistant Asthma$43,589
M01 · FY2004 · RR
Role of Bacterial Toxins in Human Skin Disease$22,233
M01 · FY2004 · RR
Mechanisms of Eczema Vaccinatum$4,973
M01 · FY2004 · RR
PATHOGENESIS AND ETIOLOGY OF KAWASAKI SYNDROME.$250,794
R37 · FY2003 · HL
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$216,858
R01 · FY2003 · AR
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$76,050
R01 · FY2003 · AR
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$50,000
R01 · FY2003 · AR
PATHOGENESIS AND ETIOLOGY OF KAWASAKI SYNDROME.$245,382
R37 · FY2002 · HL
Glucocorticoid Resistance in Acute Lung Injury$237,381
P01 · FY2002 · HL
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$216,858
R01 · FY2002 · AR
ROLE OF SUPERANTIGENS IN ATOPIC DERMATITIS$190,747
M01 · FY2002 · RR
MECHANISMS OF STEROID RESISTANT ASTHMA$190,747
M01 · FY2002 · RR
MECHANISMS OF STEROID RESISTANT ASTHMA$186,552
P01 · FY2002 · HL
PATHOGENESIS AND ETIOLOGY OF KAWASAKI SYNDROME.$240,128
R37 · FY2001 · HL
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$216,858
R01 · FY2001 · AR
MECHANISMS OF STEROID RESISTANT ASTHMA$190,747
M01 · FY2001 · RR
ROLE OF SUPERANTIGENS IN ATOPIC DERMATITIS$190,747
M01 · FY2001 · RR
MECHANISMS OF STEROID RESISTANT ASTHMA$186,552
P01 · FY2001 · HL
MECHANISMS OF STEROID RESISTANT ASTHMA$0
M01 · FY2001 · RR
ROLE OF SUPERANTIGENS IN ATOPIC DERMATITIS$0
M01 · FY2001 · RR
MECHANISMS OF STEROID RESISTANT ASTHMA$285,762
P01 · FY2000 · HL
PATHOGENESIS AND ETIOLOGY OF KAWASAKI SYNDROME.$235,025
R37 · FY2000 · HL
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASE$216,858
R01 · FY2000 · AR
MECHANISMS OF STEROID RESISTANT ASTHMA$32,212
M01 · FY2000 · RR
ROLE OF SUPERANTIGENS IN ATOPIC DERMATITIS$32,212
M01 · FY2000 · RR
ROLE OF SUPERANTIGENS IN ATOPIC DERMATITIS$0
M01 · FY2000 · RR
MECHANISMS OF STEROID RESISTANT ASTHMA$0
M01 · FY2000 · RR